India faces a rising burden of blood cancers, with around 120,000 new cases and over 70,000 deaths annually from leukemia, ...
Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize ...
India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects ...
Bengaluru-based cell and gene therapy start-up Immuneel Therapeutics on Monday announced the launch of Qartemi -- the country ...
Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST] ...
The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.
Laber was diagnosed with Stage 4 Hodgkins Lymphoma in May 2024. Her chemo treatment didn’t work, so she’s now beginning a more aggressive plan that includes a stem cell transplant and six-week ...
Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...
A New Jersey teen continued to play basketball even after he was diagnosed with stage 4B Hodgkin's lymphoma in July 2024 and ...
ThePrint on MSN4h
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in IndiaTherapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Abbie Colie is the type of person who gives without recognition and receives without forgetting. This time, though, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback